AVEO Oncology (AVEO) Adds Kevin Cullen, M.D. to Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ACCV
2. GMAB
3. IVBIY
4. IIB:IN
5. AZN
6. DRRD:IN
7. SMMT
8. RDY
9. CART
10. CLYM

Go back to AVEO Oncology (AVEO) Adds Kevin Cullen, M.D. to Board

AVEO Announces Appointment of Kevin Cullen, M.D., to Its Board of Directors

April 16, 2021 7:00 AM EDT

BOSTON--(BUSINESS WIRE)-- AVEO Oncology (Nasdaq: AVEO), a commercial and clinical development stage biopharmaceutical company, today announced the appointment of Kevin J. Cullen, M.D., to the Companys Board of Directors. A widely recognized clinical oncologist with a specialty in head and neck cancer, Dr. Cullen is the Marlene and Stewart Greenebaum Distinguished Professor in Oncology and director of the Program in Oncology at the University of Maryland School of Medicine. He also serves as director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center.

Dr. Cullen, among... More